Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis
Editat de Anne Grete Semben Limba Engleză Paperback – 20 sep 2016
Preț: 357.23 lei
Preț vechi: 376.04 lei
-5% Nou
Puncte Express: 536
Preț estimativ în valută:
68.36€ • 71.55$ • 56.89£
68.36€ • 71.55$ • 56.89£
Carte tipărită la comandă
Livrare economică 31 martie-14 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319267807
ISBN-10: 3319267809
Pagini: 126
Ilustrații: XVI, 109 p. 28 illus., 16 illus. in color.
Dimensiuni: 127 x 203 x 7 mm
Greutate: 0.13 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
ISBN-10: 3319267809
Pagini: 126
Ilustrații: XVI, 109 p. 28 illus., 16 illus. in color.
Dimensiuni: 127 x 203 x 7 mm
Greutate: 0.13 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
Cuprins
Overview of rheumatoid arthritis and mortality in relation to cardiovascular disease.- Non-atherosclerotic cardiac manifestations of rheumatoid arthritis.- Risk factors for cardiovascular disease in rheumatoid arthritis.- Cardiovascular disease risk evaluation.- Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis.- Non-pharmacological interventions for cardiovascular complications in patients with rheumatoid arthritis.- Conclusions.
Notă biografică
Anne Grete Semb, MD, PhD is a senior consultant cardiologist, the founder
and leader of a Preventive Cardio-Rheuma Clinic, the leader of the cardiovascular-rheuma research team at Diakonhjemmet hospital, Oslo, Norway and has 8 PhD students. She is a regular reviewer for several international rheumatology and cardiology journals. She has published more than 200 original scientific publications in peer-reviewed journals, book chapters and conference abstracts. She has led 3 clinical trials/studies, participated in 17 clinical trials/studies, whereas 13 trials/studies have been investigator initiated. She is a member of the European Society of Cardiology (ESC)Working Group of Cardiovascular Pharmacology and Drug Therapy. She is a member of the Eular task force group for Cardiovascular Disease Risk Management in Rheumatic Diseases in 2010 and 2015, one of the founders of and now the administrative leader of the A TransAtlantic Cardiovascular risk Consortium for Rheumatoid Arthritis (ATACC-RA).
and leader of a Preventive Cardio-Rheuma Clinic, the leader of the cardiovascular-rheuma research team at Diakonhjemmet hospital, Oslo, Norway and has 8 PhD students. She is a regular reviewer for several international rheumatology and cardiology journals. She has published more than 200 original scientific publications in peer-reviewed journals, book chapters and conference abstracts. She has led 3 clinical trials/studies, participated in 17 clinical trials/studies, whereas 13 trials/studies have been investigator initiated. She is a member of the European Society of Cardiology (ESC)Working Group of Cardiovascular Pharmacology and Drug Therapy. She is a member of the Eular task force group for Cardiovascular Disease Risk Management in Rheumatic Diseases in 2010 and 2015, one of the founders of and now the administrative leader of the A TransAtlantic Cardiovascular risk Consortium for Rheumatoid Arthritis (ATACC-RA).
Caracteristici
A concise, practical pocketbook that provides both cardiologists and rheumatologists with an up-to-date review of the background and advances for these concomitant diseases
A comprehensive overview of the current and emerging treatment recommendations for cardiovascular complications in patients with rheumatoid arthritis
Includes an evidence-based discussion of clinical approaches for these conditions, including the latest updates on the rheumatoid arthritis-specific cardiovascular disease risk calculator in this emerging treatment sector
Easily accessible text, tables, and images illustrate the key concepts discussed in the book
Includes supplementary material: sn.pub/extras
A comprehensive overview of the current and emerging treatment recommendations for cardiovascular complications in patients with rheumatoid arthritis
Includes an evidence-based discussion of clinical approaches for these conditions, including the latest updates on the rheumatoid arthritis-specific cardiovascular disease risk calculator in this emerging treatment sector
Easily accessible text, tables, and images illustrate the key concepts discussed in the book
Includes supplementary material: sn.pub/extras